Skip to main content
Clinical Trials/NCT03063853
NCT03063853
Completed
Not Applicable

Early Versus Late Removal of Surgical Staples After Cesarean Delivery. Randomized Control Trial.

Wolfson Medical Center1 site in 1 country104 target enrollmentStarted: February 1, 2017Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
104
Locations
1
Primary Endpoint
Patient and Observer Scar Assessment Scale (POSAS) scores.

Overview

Brief Summary

The optimal choice of skin closure at cesarean delivery has not yet been determined. This study aim to study the wound complications and scar healing after Surgical staples removal at postoperative day 4 and day 8 .

A randomized control trial.

Detailed Description

A randomized controlled trial in which pregnant women undergoing a scheduled Elective cesarean delivery were assigned to skin closure with surgical staples and were randomly assigned to the day of removal of surgical staples. Postoperative day 4 VS. Postoperative day 8 .

Outcome assessors were blinded to group allocation. Scars will be evaluated after 8 weeks. Primary outcome measures is Patient and Observer Scar Assessment Scale (POSAS) scores. Secondary outcome measures are complications of surgical site infection (SSI) or wound disruption (hematoma or seroma).

A group of 104 women is needed in order to achieve a clinically significant effect with a power of 80%.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • elective cesarean delivery
  • previous cesarean delivery performed using the Pfannenstiel method
  • 36-41 weeks of gestation based on first trimester ultrasound and a viable fetus.

Exclusion Criteria

  • emergency cesarean delivery
  • clinical signs of infection at the time of CD, uncontrolled
  • vunblanaced diabetes mellitus
  • history of keloids

Outcomes

Primary Outcomes

Patient and Observer Scar Assessment Scale (POSAS) scores.

Time Frame: 8 weeks postoperative

Secondary Outcomes

  • complications of surgical site infection (SSI) or wound disruption (hematoma or seroma).(8 weeks postoperative)

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials